A commercial-stage medical device company, Saluda Medical develops treatments for chronic neurological conditions leveraging ...

Mainstay Medical Holdings plc today announced the publication of positive one-year primary assessment results of the RESTORE randomized clinical trial of ReActiv8 for the treatment of intractable ...

Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

The law firm Edelson PC filed a suit in Los Angeles Superior Court today on behalf of a FedEx worker, Evangeline Iglesias, ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

Scientists Develop Coral-Inspired Material to Revolutionize Bone Repair Dec. 4, 2024 — Researchers have developed a revolutionary bone graft substitute inspired by coral which not only promotes ...

By applying enough pressure now, the thinking goes, Ukraine and its backers can enter talks from a favorable position, and ...

Nalu Expands MRI-Conditional Labeling for Peripheral Nerve Stimulation with FDA Clearance for Whole-Body MRI ...

Mainstay Medical Holdings announces outcomes from RESTORE clinical trial of ReActiv8 to treat intractable chronic low back pain: Dublin, Ireland Saturday, January 18, 2025, 18:00 ...

Nalu Medical, Inc. ("Nalu"), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients ...

A study has now shown that these patients do not show the same brain activity ... of a risky spinal surgery to alleviate intractable pain. The result gives doctors a much-needed biomarker to ...